Helicobacter Pylori Local Prevalence and Antibiotic Resistance

Launched by TECHNICAL UNIVERSITY OF MUNICH · Sep 27, 2022

Keywords

ClinConnect Summary

This clinical trial is looking into the infection caused by Helicobacter pylori (H. pylori), a bacteria that can lead to stomach issues like gastritis and even gastric cancer. The researchers want to understand how common this infection is in the local area and how well the antibiotics we currently have work against it. They will collect information about how many people have H. pylori infections and check if the bacteria are resistant to treatment. By doing this, they hope to find better ways to diagnose and treat these infections and identify individuals who may be at higher risk for developing stomach cancer.

To participate in this study, you need to be at least 18 years old and provide your consent to be part of the research. If you join, you can expect to undergo an endoscopic examination, which is a procedure that allows doctors to see inside your stomach and take samples if necessary. The study is currently recruiting participants of all genders, so if you or someone you know is interested and meets the criteria, it could be a valuable opportunity to contribute to important research on H. pylori infections.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Minimum age of 18 years
• • informed consent for HelicoPTER study
• • informed consent for HEPY biobank
• Exclusion Criteria:
• • no capacity to consent